Furtner, J.; Nenning, K.-H.; Roetzer, T.; Gesperger, J.; Seebrecht, L.; Weber, M.; Grams, A.; Leber, S.L.; Marhold, F.; Sherif, C.;
et al. Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. Cancers 2021, 13, 566.
https://doi.org/10.3390/cancers13030566
AMA Style
Furtner J, Nenning K-H, Roetzer T, Gesperger J, Seebrecht L, Weber M, Grams A, Leber SL, Marhold F, Sherif C,
et al. Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. Cancers. 2021; 13(3):566.
https://doi.org/10.3390/cancers13030566
Chicago/Turabian Style
Furtner, Julia, Karl-Heinz Nenning, Thomas Roetzer, Johanna Gesperger, Lukas Seebrecht, Michael Weber, Astrid Grams, Stefan L. Leber, Franz Marhold, Camillo Sherif,
and et al. 2021. "Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma" Cancers 13, no. 3: 566.
https://doi.org/10.3390/cancers13030566
APA Style
Furtner, J., Nenning, K. -H., Roetzer, T., Gesperger, J., Seebrecht, L., Weber, M., Grams, A., Leber, S. L., Marhold, F., Sherif, C., Trenkler, J., Kiesel, B., Widhalm, G., Asenbaum, U., Woitek, R., Berghoff, A. S., Prayer, D., Langs, G., Preusser, M.,
& Wöhrer, A.
(2021). Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. Cancers, 13(3), 566.
https://doi.org/10.3390/cancers13030566
